Category: Stock Market

In afternoon trade the S&P/ASX 200 Index (ASX: XJO) looks set to record a disappointing decline. At the time of writing, the benchmark index is down 0.65% to 6,626.6 points.

Four shares that have not let that hold them back are listed below. Here’s why they are pushing higher:

A2 Milk Company Ltd (ASX: A2M)

The a2 Milk share price is up 1.5% to $10.40. This appears to be down to bargain hunters swooping in today to take advantage of a significant pullback in the infant formula company’s share price. Its shares were sold off last week after it was forced to downgrade its guidance due to weakness in the daigou channel.

Doctor Care Anywhere Ltd (ASX: DOC)

The Doctor Care Anywhere share price has jumped 7% higher to $1.29. This has been driven by an announcement that revealed that the UK-based telehealth company has signed a new channel agreement with Allianz Partners. It is one of the world’s largest insurance and assistance companies. This agreement will give Allianz Partners international private medical insurance policyholders and their dependents based in Europe access to Doctor Care Anywhere’s digital health services.

McPherson’s Ltd (ASX: MCP)

The McPherson’s share price is up 5% to $1.39. Investors have been buying the beauty products company’s shares following the release of an update after the market close on Monday. That update revealed that McPherson’s is on track to achieve its previous first half underlying profit before tax guidance which was recently withdrawn. It is expecting underlying profit before tax in the range of $6.5 million to $7.5 million. This represents an 11.8% to 23.5% decline on the prior corresponding period.

Volpara Health Technologies Ltd (ASX: VHT)

The Volpara share price has risen 3.5% to $1.37. This solid gain has been driven by news that it has signed a five-year software-as-a-service (SaaS) contract with BreastScreen Queensland following a successful pilot trial. BreastScreen Queensland is the third largest public breast screening program in Australia. The contract is initially for Volpara’s quality assurance platform, VolparaEnterprise. But allows for the expansion of services to include VolparaDensity and VolparaLive.

More reading

• ASX 200 down 0.85%: ANZ CFO resigns, tech shares tumble, iron ore jumps
• Volpara (ASX:VHT) share price jumps 5% in morning trading. Here’s why
• Why brokers slashed their A2 Milk (ASX:A2M) share price target
• Why the Doctor Care Anywhere (ASX:DOC) share price is surging 11% higher
• Why the McPherson’s (ASX:MCP) share price could charge higher on Tuesday

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and recommends VOLPARA FPO NZ. The Motley Fool Australia owns shares of and has recommended A2 Milk. The Motley Fool Australia has recommended VOLPARA FPO NZ. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post Why a2 Milk, Doctor Care Anywhere, McPherson’s, & Volpara are pushing higher appeared first on The Motley Fool Australia.

from The Motley Fool Australia https://ift.tt/3riBX10

The Archer Materials Ltd (ASX: AXE) share price leapt higher on open this morning on news the company has sold 2 mineral exploration licenses. 

At the time of writing, the Archer share price is trading 1.9% higher at 53.5 cents. Here’s what you need to know.

What did Archer Materials report?

Today, Archer Materials advised it has entered into a legally binding agreement to sell 2 of its mineral exploration licenses on South Australia’s Eyre Peninsula. The sale does not need Archer shareholder approval.

Baudin Minerals, a private company, will pay $2.0 million for the licenses, along with a bonus share payment after it lists on a stock exchange, as planned. In addition, Archer will receive a 2% net smelter return royalty if Baudin discovers and begins mining for minerals.

Archer also revealed it will retain the right to explore for, and mine, graphite on both tenements.

The company said the sale matched its business strategy to sell off non-core mineral exploration assets, using the funds for its materials technology development. Its core focus is developing its CQ room temperature quantum computing chip and graphene-based A1 Biochip.

Commenting on the sale, Archer chairman Greg English said:

We believe this is a good deal for our shareholders. The proceeds from the sale of the tenements will assist in the funding of our tech-related activities.

In addition to the upfront payment at completion, Archer will also receive royalty payments should the buyer discover minerals and commence mining on the tenements. The royalty would allow the company to financially benefit from any future development of these projects.

Archer share price and company snapshot

Archer is a materials technology company. It focuses on developing cutting edge technology in quantum computing, reliable energy and biotechnology. Archer’s Australian-based mineral exploration projects span critical minerals like graphite, copper, tungsten, cobalt, and more. Archer Materials’ shares listed on the ASX in August 2007.

Despite plummeting 48% in the first weeks of February during the COVID-19 market panic, Archer shareholders are well into the green in 2020. Year-to-date, the Archer share price is up a whopping 234%. By comparison the All Ordinaries Index (ASX: XAO) is up just over 1%.

More reading

• Why the Think Childcare (ASX:TNK) share price is up 2% today
• The Pensana (ASX:PM8) share price shot up 14% higher today. Here’s why
• ASX 200 Weekly Wrap: ASX hits new post-March high
• Why the CleanSpace (ASX:CSX) share price is climbing today
• Recent development sends the Antisense (ASX:ANP) share price soaring 45%

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post Why the Archer Materials (ASX:AXE) share price is up 2% today appeared first on The Motley Fool Australia.

from The Motley Fool Australia https://ift.tt/2KtWDCP

Respected fund manager Wilson Asset Management (WAM) has recently identified two ASX shares that it owns in its portfolio.

WAM operates several listed investment companies (LICs). Two of those LICs are WAM Capital Limited (ASX: WAM) and WAM Leaders Ltd (ASX: WLE).

There’s also one called WAM Active Limited (ASX: WAA) which looks at businesses it thinks are the most undervalued.  

WAM says WAM Active invests in market mispricing opportunities in the Australian market.  

The WAM Active portfolio has delivered gross returns (that’s before fees, expenses and taxes) of 12% per annum since inception in January 2008, which is superior to the Bloomberg AusBond Bank Bill Index return per annum of 3.1%.  

These are the two ASX shares that WAM outlined in its most recent monthly update:

Graincorp Ltd (ASX: GNC)

According to the ASX, Graincorp has a market capitalisation of $980 million.

The fund manager describes GrainCorp as a business that handles, receives and stores agricultural commodities including grain and assists with the transporting, testing, storing and marketing of agricultural products.

Graincorp recently released its FY20 results for the year to September 2020 that showed a “significant lift” in financial performance despite the impact of the drought with underlying earnings before interest, tax, depreciation and amortisation (EBITDA) from continued operations of $108 million and a fully franked dividend of 7 cents per share.

The company also reported that its underlying net profit after tax (NPAT) for continuing operations was a $16 million loss, although this was improved from the $158 million loss in FY19. The statutory net profit was $343 million.

WAM Active said that the FY21 outlook for the company is strong with a record east coast crop tracking ahead of expectations. Graincorp is leveraged to an increase in crop volumes and the fund manager believes that the efficiency gains and cost savings implemented by management over the past years will materialise in financial performance.

Management said that the 2020/2021 winter crop will be similar size to the FY17 harvest (subject to ongoing weather conditions and other variables).

At the current Graincorp share price, it’s valued at 15x FY21’s estimated earnings according to projections on Commsec.

Adore Beauty Group Ltd (ASX: ABY)

According to the ASX, Adore Beauty has a market capitalisation of $480 million.

Adore Beauty recently listed on the ASX at the end of October 2020. It’s Australia’s only exclusively-online beauty retailer. WAM said the company was launched in 2000 in the founder’s backyard.

The company has grown to now stock more than 230 leading beauty brands, offering customers access to more than 11,000 products. The company had more than 18.5 million website users across its Australian and New Zealand websites in FY20. At 30 June 2020 it had serviced more than 590,000 active customers.

WAM pointed out that in November, promotional sales during the Black Friday and cyber weekend proved stronger than Adore Beauty’s initial forecasts. That’s why Adore Beauty increased its forecast revenue guidance for the FY21 first half to approximately $95.2 million, which was more than the prospectus forecast by 7%.

At the time of the update, Adore Beauty CEO Tennealle O’Shannessy said: “We are pleased to report strong sales ahead of our prospectus forecasts. The business has continued to scale, deliver content and meet the needs of our customers at a time when they need it most.”

The expected uplift in revenue is also anticipated by the company to have a positive impact on the EBITDA forecast for the first half of the 2021 financial year.

More reading

• 2 exciting mid cap ASX shares to buy for the long term
• Here’s how Nuix (ASX:NXL) and these recent IPOs are performing since listing
• 2 highly rated mid cap ASX shares to buy for 2021
• Wilson Asset Management (WAM) thinks these 2 ASX shares are a buy
• Westpac (ASX:WBC) tips Australian dollar to hit 80 US cents in 2021

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post 2 top ASX shares to buy according to WAM appeared first on The Motley Fool Australia.

from The Motley Fool Australia https://ift.tt/2WzPUK7

At lunch on Tuesday the S&P/ASX 200 Index (ASX: XJO) is on course to record a sizeable decline. The benchmark index is down 0.85% to 6,613 points.

Here’s what has been happening on the market today:

ANZ CFO resigns.

The Australia and New Zealand Banking GrpLtd (ASX: ANZ) share price has come under pressure on Tuesday after announcing the exit of its chief financial officer (CFO). According to the release, the bank’s CFO, Michelle Jablko, has decided to leave the company and take up a senior role at toll road operator Transurban Group (ASX: TCL). Ms Jablko will transition her duties over the coming months to current Group General Manager Internal Audit Shane Buggle, who will be appointed Acting Chief Financial Officer.

Tech shares tumble.

Many of Australia’s leading tech shares are trading lower on Tuesday. The likes of Nearmap Ltd (ASX: NEA) and Zip Co Ltd (ASX: Z1P) are trading notably lower and weighing heavily on the the S&P ASX All Technology Index (ASX: XTX). The tech index is down a sizeable 1.2% lower at the time of writing. This follows a soft night of trade on Wall Street’s tech-focused Nasdaq index.

Iron ore price hits a nine-year high.

Mining giants BHP Group Ltd (ASX: BHP), Fortescue Metals Group Limited (ASX: FMG), and Rio Tinto Limited (ASX: RIO) are all dropping lower today despite the iron ore price jumping higher overnight. According to CommSec, the spot iron ore price jumped a massive 7.8% higher to a nine-year high of US$176.90 a tonne. This has been driven by concerns over a supply outage at one of Vale’s mines in Brazil.

Best and worst ASX 200 performers.

The best performer on the ASX 200 on Tuesday has been the A2 Milk Company Ltd (ASX: A2M) share price with a 1.5% gain. Bargain hunters appear to be snapping up shares after a heavy decline last week. The worst performer has been the Ramelius Resources Limited (ASX: RMS) share price with a 7% decline. A number of gold miners are dropping lower today, but Ramelius is leading the pack.

More reading

• Transurban (ASX:TCL) share price wobbles on new CFO announcement
• Why brokers slashed their A2 Milk (ASX:A2M) share price target
• The Unibail Rodamco Westfield (ASX:URW) share price has dipped 3% today
• Iron ore hits 9-year high: What this means for BHP, Fortescue, & Rio Tinto
• Is the Zip (ASX:Z1P) share price a buy yet?

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of Nearmap Ltd. and ZIPCOLTD FPO. The Motley Fool Australia owns shares of and has recommended A2 Milk. The Motley Fool Australia owns shares of Transurban Group. The Motley Fool Australia has recommended Nearmap Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post ASX 200 down 0.85%: ANZ CFO resigns, tech shares tumble, iron ore jumps appeared first on The Motley Fool Australia.

from The Motley Fool Australia https://ift.tt/3mFnMj5

In late morning trade the S&P/ASX 200 Index (ASX: XJO) is on course to record another decline. At the time of writing, the benchmark index is down 0.4% to 6,642.2 points.

Four shares that are falling more than most today are listed below. Here’s why they are dropping lower:

AGL Energy Limited (ASX: AGL)

The AGL share price is down 3% to $12.17. Investors have been selling the energy company’s shares after it downgraded its guidance on Monday afternoon. AGL now expects its net profit after tax to be in the range of $560 million-$660 million, down from $500 million-$580 million previously. This represents an 11% reduction at the midpoint. This led to analysts at Morgans cutting their price target on the company’s shares to $11.18 this morning.

Mesoblast limited (ASX: MSB)

The Mesoblast share price has continued to sink lower and is down a further 4% to $2.21. Investors have been selling the biotech company’s shares after the release of a couple of disappointing updates last week. Both its advanced chronic heart failure and COVID-19 Acute Respiratory Distress Syndrome trials failed to achieve their primary endpoints.

WiseTech Global Ltd (ASX: WTC)

The WiseTech share price has fallen 2% to $30.13. Investors have been selling the logistics solutions company’s shares after it was the subject of a short seller attack by Viceroy Research. Its analysts claim many of the 37 acquisitions made by WiseTech over the past four years are from distressed sales or bankrupt companies with revenues falling post-acquisition.

Woodside Petroleum Limited (ASX: WPL)

The Woodside share price is down almost 2.5% to $22.53. Investors have been selling Woodside and other energy producers after oil prices tumbled lower overnight. Fears over a new strain of COVID-19 in Europe has led to concerns over demand for energy. Both WTI and Brent crude oil prices fell 2% during overnight trade.

More reading

• 5 things to watch on the ASX 200 on Tuesday
• Why the AGL (ASX:AGL) share price has fallen 6% today
• Under attack! Why the WiseTech Global (ASX:WTC) share price is down 9%
• Why Elixinol Global, Flight Centre, Mesoblast, & WiseTech shares are dropping lower
• ASX 200 down 0.4%: NIB jumps, a2 Milk rebounds, WiseTech sinks lower

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of WiseTech Global. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post Why AGL, Mesoblast, WiseTech, & Woodside are dropping lower appeared first on The Motley Fool Australia.

from The Motley Fool Australia https://ift.tt/34vQzQP

The Volpara Health Technologies Ltd (ASX: VHT) share price has jumped by almost 5% this morning, after the company announced a new contract with BreastScreen Queensland.

At the time of writing, the Volpara share price is trading at $1.38, up by 6 cents.

What’s driving the Volpara share price? 

The Volpara share price is on the rise today after the medical technology company reported it has signed a five-year software-as-a-service (SaaS) contract with BreastScreen Queensland following a successful pilot trial.

BreastScreen Queensland is the third largest public breast screening program in Australia, and is head-quartered on the Gold Coast.

The contract, initially for Volpara’s quality assurance platform, VolparaEnterprise, will allow for the expansion of services to include VolparaDensity and VolparaLive.

The initial stage will involve the roll-out of VolparaEnterprise to 11 BreastScreen Queensland services operating in Brisbane and elsewhere in the state.

The BreastScreen Queensland services comprise 69 gantries and 43 sites that include 10 mobile units, covering 171 radiologists and technologists.

The roll-out of VolparaEnterprise to BreastScreen Queensland has already begun, and Volpara expects it to go live in early 2021.

Although the terms and conditions of the contract will remain confidential, Volpara CEO Dr Ralph Highnam believes the deal will put Volpara’s name on the world map, saying:

We are delighted to now have BreastScreen Queensland signing up to use our software, making it the second major public breast cancer screening programme in Australia signed up to Volpara products.

This is news that will resonate around the world, and we are extremely pleased that our software will be helping women in the fight against breast cancer, including women in the lives of many of our long-term investors.

What is Volpara?

Volpara is a New Zealand-based provider of breast imaging analytical products that improve clinical decision-making and the early detection of breast cancer.

It suite of software helps clinicians understand their patients, and administrators better understand their practices.

Today’s announcement is the second major contract the company has been able to secure in the space of just one week.

Last Friday, Volpara also announced it has signed a five-year contract with a major United States-based customer, US Radiology.

That contract was for the delivery and ongoing use of the Volpara Breast Health Platform.

About the Volpara share price in 2020

In its latest update to the market in November, the company reported net revenue of NZ$9.5 million for the first half of FY21, up 38% on the prior corresponding period.

However, that top line revenue resulted in a net loss after tax of NZ$8 million, compared to a NZ$8.9 million loss in 2019.

This performance has been reflected in the Volpara share price, which is down 25% this year.

Based on the current share price, the company commands a market capitalisation of $329 million.

More reading

• The Volpara (ASX:VHT) share price is flat today despite announcement
• 3 quality SaaS ASX shares to buy
• 3 exciting small cap ASX shares to buy
• Volpara (ASX:VHT) share price falls on half-year results

Eddy Sunarto has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and recommends VOLPARA FPO NZ. The Motley Fool Australia has recommended VOLPARA FPO NZ. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post Volpara (ASX:VHT) share price jumps 5% in morning trading. Here’s why appeared first on The Motley Fool Australia.

from The Motley Fool Australia https://ift.tt/3peWx0I

The Transurban Group (ASX: TCL) share price has been wobbly in morning trade despite the company announcing a change in the management team. At the time of writing, the toll road operator’s shares are inching up 0.43% to $14.06.

What did Transurban announce?

Transurban advised it has appointed Ms Michelle Jablko as the new chief financial officer.

Ms Jablko will leave her role as chief financial officer with Australia and New Zealand Banking Group Ltd (ASX: ANZ). Having held that position since 2016, Ms Jablko was also a member of the bank’s executive committee.

Ms Jablko has developed her skills across large and multinational organisations and brings a wealth of experience to Transurban. Her core competencies involve capital efficiency and allocation, as well as taking lead on merger and acquisition deals.

Prior to her role at ANZ, Ms Jablko spent most of her career in investment banking, most notably working for UBS and Greenhill Australia. In the latter, she held the role of managing director.

In her early career, Ms Jablko was employed by Allens Linklaters, which focuses on mergers and acquisitions, banking, tax and finance law.

Ms Jablko will join the Transurban team in the new year and be based in its offices in Melbourne, Victoria.

CEO commentary

Transurban CEO, Mr Scott Charlton, spoke highly about Ms Michelle Jablko and the new appointment:

We are delighted that Michelle will be joining Transurban Group and I believe that with her leadership, capabilities and experience she will make a significant contribution to the Transurban business.

About the Transurban share price

The Transurban share price has almost recovered to pre-COVID-19 levels. Its shares are currently down just under 10% from their 52-week high of $16.44 in January. However, since the beginning of June, the Transurban share price has mostly stagnated.

The company has a current market capitalisation of $38.2 billion.

More reading

• ANZ (ASX:ANZ) share price under pressure after CFO resigns
• ASX 200 Weekly Wrap: ASX hits new post-March high
• Top brokers name 3 ASX shares to sell next week
• 2 blue chip ASX dividend shares to buy next week
• Brokers name 3 ASX shares to buy right now

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of Transurban Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post Transurban (ASX:TCL) share price wobbles on new CFO announcement appeared first on The Motley Fool Australia.

from The Motley Fool Australia https://ift.tt/3h905OX

The Ramsay Health Care Limited (ASX: RHC) share price has lifted this morning after the company announced a new contract in the United Kingdom.

At the time of writing, the Ramsay share price is up 0.98% at $63.11.

What did Ramsay announce?

In today’s release, Ramsay advised it has signed a new volume-based agreement with NHS England (NHS). Ramsay will make its services available to the NHS to help meet the ongoing COVID-19 demands.

The NHS, or National Health Service, is the United Kingdom’s publicly-funded healthcare system.

The new agreement will run from 1 January to 31 March next year, unless terminated earlier on 6 weeks’ notice. It replaces an existing cost recovery agreement with NHS, which completes on 31 December 2020.

The company says NHS may trigger a peak surge period on 7 days’ notice, should Ramsay’s capacity be required to enable the NHS to respond to COVID-19 cases.

In these circumstances, the affected hospitals will be paid on a cost recovery basis.

Quick take on Ramsay Health Care

Ramsay Health Care is a global private hospital provider. Its facilities cater for a broad range of health care needs from primary care to highly complex surgery, as well mental health care and rehabilitation.

Ramsay Australia has around 36% market share of the private hospital market in Australia, with demographic positioning skewed to urban and mid- to high-income areas.

The Australian business has been a good cash generator for the company, as more Australians are on private health insurance (PHI) compared to our European counterparts.

According to recent data from APRA (Australian Prudential Regulatory Authority), 45% of Australians have PHI. In addition, more than 80% of private hospital revenue in Australia comes from private insurance.

This compares with 20% private insurance revenue in the United Kingdom and France, and 10% in the Nordic countries.

The cash revenue generated from Ramsay’s Australian business has enabled the company to expand overseas. Its most recent acquisition is the Swedish-based private hospital company Capio.

How has the Ramsay share price performed in 2020

The Ramsay share price is down 9.5% in 2020. The company delivered net profit after tax (NPAT) of $337 million for FY20, compared to $591 million for FY19.

However in its latest first-quarter update to the market, Ramsay Australia reported a 1.5% increase in total revenue during the first quarter of FY21. This reflects a 1.7% increase in surgical admissions.

Overseas, Ramsay UK business has also experienced a recovery in private care in recent months.

Given near-term uncertainties however, Ramsay declined to give any guidance for fiscal 2021. The company commands a market cap of $14.3 billion.

More reading

• These are 8 of the best performing ASX healthcare shares of 2020 so far
• 3 reasons why Soul Patts (ASX:SOL) is a great ASX dividend share
• 2 top ASX blue chip shares to buy
• ASX 200 events this week that could move the market

Motley Fool contributor Eddy Sunarto has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Ramsay Health Care Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post Ramsay Health Care (ASX:RHC) share price climbs after this announcement appeared first on The Motley Fool Australia.

from The Motley Fool Australia https://ift.tt/3pdTNQZ

The investments regulator has kept the heat on ASX Ltd (ASX: ASX) for its 16 November systems crash, ordering it to conduct an independent review.

Australian Securities and Investments Commission (ASIC) continues to assess whether ASX is fit to hold its share market licence. 

In a sign that this assessment is not casting the best light on the company, ASIC and the Reserve Bank of Australia have notified ASX that it should perform an independent review within the next 6 months.

The concern for ASX holding the market licence is whether it “has sufficient financial, technological and human resources to operate its markets”.

Critics have pointed to the virtual monopoly the company enjoys, citing that it provides no incentive for it to invest sufficiently in infrastructure.

OpenMarkets chief executive Ivan Tchourilov said in October after an ASX website crash that its dominance was unhealthy.

“The industry is concerned that ASX has too much power to dictate play and there isn’t much of an opportunity for competitors to create a diverse environment that will ultimately benefit customers.”

ASX Ltd confirmed to The Motley Fool that it will complete an independent report. 

“We are focused on operating a safe and reliable market, and restoring confidence,” said an ASX spokesperson.

Broking firms told off for not having a backup to ASX

ASIC also took aim at broking firms for not having a backup to ASX available for their clients.

The sole reliance on the ASX only consolidates the monopoly. The regulator is also concerned that not having a backup fails brokers’ “best execution” obligations to clients.

Chi-X is an alternative market in Australia where trades for a subset of ASX-listed shares can be executed.

ASIC is alarmed at how it didn’t experience an increase in volume on 16 November when the ASX was down for most of the day.

“Participants’ duties to their clients, including the obligation to take reasonable steps to obtain best execution, do not fall away where there has been a market outage or disruption,” said ASIC commissioner Cathie Armour.

“The behaviour of market participants during this outage indicated too many firms are reliant on the ASX to trade listed securities. With a fully functioning alternative venue available, we are examining why far more trading did not occur on Chi-X on the day of the outage.”

In the coming year, the regulator will review what business continuity arrangements market participants (ie brokers) have in place.

Some broking platforms, like CommSec, already have Chi-X available as an alternative place of trade execution. Such providers were able to continue to provide a partial service to their clients on 16 November.

More reading

• Why zero-fee apps will never exist for ASX shares
• Top brokers name 3 ASX shares to sell next week
• Will ASX kick out companies that don’t have board diversity?
• Meet the most unpopular ASX large cap stock according to analysts
• Why ASX, Kogan, Myer, & Northern Star shares are dropping lower

Motley Fool contributor Tony Yoo has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post ASX ordered to take a good look in the mirror appeared first on The Motley Fool Australia.

from The Motley Fool Australia https://ift.tt/3pkjJe1

The S&P/ASX 50 index may not be as well-known as the S&P/ASX 200 Index (ASX: XJO), but it is arguably just as important.

This exclusive index is home to 50 of the largest companies on the Australian share market. These include household names and companies that are regarded as true blue chip shares.

While not all shares on the index are necessarily in the buy zone, two that come highly rated are listed below:

Goodman Group (ASX: GMG)

Goodman Group is one of the world’s leading integrated commercial and industrial property companies. It owns, develops, and manages industrial real estate globally. This includes warehouses, large scale logistics facilities, and business and office parks across a total of 17 countries. 

The company has been growing at a solid rate over the last decade thanks to its high quality portfolio. Management has curated its portfolio to give it exposure to industries benefiting from structural tailwinds such as online, logistics, food, consumer goods, and the digital economy.

Morgan Stanley is a fan of the company and was pleased with its recent first quarter update. It believes the company’s focus on strong locations is paying off. The broker has an overweight rating and $20.90 price target on its shares.

Xero Limited (ASX: XRO)

Xero is actually the newest addition to the ASX 50 index, having only joined it on Monday following the quarterly rebalance. It is a leading cloud-based business and accounting software provider with a focus on small to medium sized businesses.

Thanks to its highly successful evolution into a full service small business solution over the last few years, Xero has been growing its customer numbers and recurring revenues at a rapid rate. This has underpinned very strong returns for shareholders.

Pleasingly, due to the quality of its offering, the ongoing shift to cloud-based solutions, its global market opportunity, and burgeoning app ecosystem, Xero has been tipped for more of the same in the future.

Analysts at Goldman Sachs are very positive on its prospects. They recently put a buy rating and $157.00 price target on the company’s shares.

More reading

• The most crazy ASX chart of 2020
• Buy these ASX blue chip shares for your retirement portfolio
• How useful is the P/E ratio in assessing ASX shares?
• These are the 5 best ASX real estate shares of 2020
• Why 2021 may be an even better year for ASX investors

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of Xero. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post 2 of the best ASX 50 shares to buy today appeared first on The Motley Fool Australia.

from The Motley Fool Australia https://ift.tt/3mJlJKW